Rehemtulla A - Search Results

1

Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells.

Contessa JN, Bhojani MS, Freeze HH, Rehemtulla A, Lawrence TS. Contessa JN, et al. Among authors: rehemtulla a. Cancer Res. 2008 May 15;68(10):3803-9. doi: 10.1158/0008-5472.CAN-07-6389. Cancer Res. 2008. PMID: 18483264 Free PMC article.

2

High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer.

Nyati MK, Sreekumar A, Li S, Zhang M, Rynkiewicz SD, Chinnaiyan AM, Rehemtulla A, Lawrence TS. Nyati MK, et al. Among authors: rehemtulla a. Cancer Res. 2002 Apr 15;62(8):2337-42. Cancer Res. 2002. PMID: 11956093

3

Noninvasive real-time imaging of apoptosis.

Laxman B, Hall DE, Bhojani MS, Hamstra DA, Chenevert TL, Ross BD, Rehemtulla A. Laxman B, et al. Among authors: rehemtulla a. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16551-5. doi: 10.1073/pnas.252644499. Epub 2002 Dec 10. Proc Natl Acad Sci U S A. 2002. PMID: 12475931 Free PMC article.

4

Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.

Zhang M, Li S, Nyati MK, DeRemer S, Parsels J, Rehemtulla A, Ensminger WD, Lawrence TS. Zhang M, et al. Among authors: rehemtulla a. Cancer Res. 2003 Feb 1;63(3):658-63. Cancer Res. 2003. PMID: 12566311

5

Evaluation of cancer therapy using diffusion magnetic resonance imaging.

Ross BD, Moffat BA, Lawrence TS, Mukherji SK, Gebarski SS, Quint DJ, Johnson TD, Junck L, Robertson PL, Muraszko KM, Dong Q, Meyer CR, Bland PH, McConville P, Geng H, Rehemtulla A, Chenevert TL. Ross BD, et al. Among authors: rehemtulla a. Mol Cancer Ther. 2003 Jun;2(6):581-7. Mol Cancer Ther. 2003. PMID: 12813138 Review.

6

Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy.

Rehemtulla A, Hall DE, Stegman LD, Prasad U, Chen G, Bhojani MS, Chenevert TL, Ross BD. Rehemtulla A, et al. Mol Imaging. 2002 Jan-Mar;1(1):43-55. doi: 10.1162/15353500200200005. Mol Imaging. 2002. PMID: 12920860

7

Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy.

Chenevert TL, Meyer CR, Moffat BA, Rehemtulla A, Mukherji SK, Gebarski SS, Quint DJ, Robertson PL, Lawrence TS, Junck L, Taylor JM, Johnson TD, Dong Q, Muraszko KM, Brunberg JA, Ross BD. Chenevert TL, et al. Among authors: rehemtulla a. Mol Imaging. 2002 Oct;1(4):336-43. doi: 10.1162/15353500200221482. Mol Imaging. 2002. PMID: 12926229 Review.

8

TRAIL and anti-tumor responses.

Bhojani MS, Rossú BD, Rehemtulla A. Bhojani MS, et al. Among authors: rehemtulla a. Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S71-8. Cancer Biol Ther. 2003. PMID: 14508083 Review.

9

Extracellular expression of cytosine deaminase results in increased 5-FU production for enhanced enzyme/prodrug therapy.

Rehemtulla A, Hamstra DA, Kievit E, Davis MA, Ng EY, Dornfeld K, Lawrence TS. Rehemtulla A, et al. Anticancer Res. 2004 May-Jun;24(3a):1393-9. Anticancer Res. 2004. PMID: 15274300 Free article.

10

The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.

Hamstra DA, Lee KC, Tychewicz JM, Schepkin VD, Moffat BA, Chen M, Dornfeld KJ, Lawrence TS, Chenevert TL, Ross BD, Gelovani JT, Rehemtulla A. Hamstra DA, et al. Among authors: rehemtulla a. Mol Ther. 2004 Nov;10(5):916-28. doi: 10.1016/j.ymthe.2004.07.022. Mol Ther. 2004. PMID: 15509509 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

227 results

Search Page